Cellectis SA (CLLS)
3.08
+0.04
(+1.32%)
USD |
NASDAQ |
May 15, 15:28
Cellectis Revenue (Quarterly): 0.283M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.283M |
| September 30, 2023 | 0.155M |
| June 30, 2023 | 0.179M |
| March 31, 2023 | 0.139M |
| December 31, 2022 | 16.02M |
| September 30, 2022 | 0.176M |
| June 30, 2022 | 1.306M |
| March 31, 2022 | 1.666M |
| December 31, 2021 | -14.74M |
| September 30, 2021 | 8.311M |
| June 30, 2021 | 11.18M |
| March 31, 2021 | 25.60M |
| December 31, 2020 | -8.98M |
| September 30, 2020 | 6.179M |
| June 30, 2020 | 2.90M |
| March 31, 2020 | 50.13M |
| December 31, 2019 | 4.434M |
| September 30, 2019 | 8.488M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.152M |
| March 31, 2019 | 1.036M |
| December 31, 2018 | 0.869M |
| September 30, 2018 | 0.905M |
| June 30, 2018 | 5.049M |
| March 31, 2018 | 6.04M |
| December 31, 2017 | 5.772M |
| September 30, 2017 | 6.122M |
| June 30, 2017 | 6.494M |
| March 31, 2017 | 6.737M |
| December 31, 2016 | 8.106M |
| September 30, 2016 | 11.26M |
| June 30, 2016 | 17.60M |
| March 31, 2016 | 7.908M |
| December 31, 2015 | 29.58M |
| September 30, 2015 | 8.550M |
| June 30, 2015 | 8.219M |
| March 31, 2015 | 9.127M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-14.74M
Minimum
Dec 2021
50.13M
Maximum
Mar 2020
6.030M
Average
1.666M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Genfit SA | 15.36M |
| Biophytis SA | -- |
| Edap TMS SA | 21.12M |
| Adaptimmune Therapeutics PLC | 0.231M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.86M |
| Total Expenses (Quarterly) | 29.86M |
| EPS Diluted (Quarterly) | -0.70 |
| Enterprise Value | 48.53M |
| Gross Profit Margin (Quarterly) | 40.99% |
| Profit Margin (Quarterly) | -15.15K% |
| Earnings Yield | -57.79% |
| Normalized Earnings Yield | -58.31 |